IDE-251

N/A

Report date: 2025/01/09 11:53:01
NMEFirst In Class

Base Information

Drug NameIDE-251
Drug Alias NameIDE-251IDE251
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone acetyltransferase KAT6A inhibitorsHistone acetyltransferase KAT6B inhibitorsHistone acetyltransferase KAT7 inhibitors
TargetsHistone acetyltransferase KAT6AHistone acetyltransferase KAT6BHistone acetyltransferase KAT7
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIdeaya Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesIdeaya Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A